Our GLP1R fluorescent antagonist shows high affinity for GLP1 receptor (pIC50 = 7.2 for GLP1R) modulating the receptor by orthosteric antagonism. The efficacy and potency of LUXendin551 (CELT-111) as a GLP1R ligand was confirmed by inhibition of GLP-1-stimulated cAMP levels in SNAP-GLP1R: HEK293 cells. LUXendin551 (CELT-111) has been used in a variety of imaging applications, including widefield/confocal/2-photon microscopy in live and fixed mammalian cells and tissue, as well as anaesthetized mice.

*2º Image: Widefield image of live CHO-K1:SNAP-GLP1R cells labeled with 200 nM LUXendin551. Scale bar = 40 micrometer.

More information and applications

https://chemrxiv.org/engage/chemrxiv/article-details/60ff0d5a393cc904c94f1f18

LUXendin551 GLP1 receptor (GLP1R) fluorescent antagonist (551/576) (CELT-111)

3 nmol vial that allows to prepare 30 mL of 100 nM working solution to test GLP1R. One vial is sufficient for injecting one mouse.

Working concentration might differ among assay designs

385,00